Annual EBITDA
-$269.00M$22.00M+7.56%
Summary
- Current Value
- As of today, RCUS annual EBITDA is -$269.00M, up +7.56% on
- Historical Performance
- RCUS annual EBITDA is down -555.93% over the past 3 years, and down -231.56% over the past 5 years
- All-Time High Comparison
- RCUS annual EBITDA is currently -555.93% below its historical high of $59.00M set on
- 3-Year Low Comparison
- RCUS annual EBITDA is +7.56% above its 3-year low of -$291.00M reached on
- Sector Comparison
- RCUS annual EBITDA is higher than 4.92% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$269.00M | +7.6% | -555.9% | -231.6% | -1494.7% | |
| Quarterly EBITDA | -$140.00M | -35.9% | -112.8% | -4224.9% | -1954.6% | |
| TTM EBITDA | -$365.00M | -27.6% | -511.3% | -327.3% | -5256.6% | |
| Price | $21.35 | +43.1% | +15.5% | -30.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $258.00M | +120.5% | -32.6% | +1620.0% | +100.0% | |
| Annual EPS | -$3.14 | +24.3% | -539.8% | -62.5% | -664.8% | |
| Annual EBIT | -$279.00M | +6.7% | -607.3% | -229.4% | -1434.5% | |
| Annual Net Income | -$283.00M | +7.8% | -635.7% | -234.1% | -1474.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$258.00M | N/A | -4.3% |
| 5Y | $59.00M | -555.9% | |
| All | $59.00M | -555.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$291.00M | +7.6% | |
| 5Y | -$291.00M | +7.6% | |
| All | -$291.00M | +7.6% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$269.00M | +7.6% | |
| -$291.00M | -12.8% | |
| -$258.00M | -537.3% | |
| $59.00M | +149.2% | |
| -$120.00M | -47.9% |
| Year | Value | Change |
|---|---|---|
| -$81.13M | -58.5% | |
| -$51.20M | -0.7% | |
| -$50.83M | -201.3% | |
| -$16.87M | - |
FAQ
What is the current annual EBITDA of RCUS?
As of today, RCUS annual EBITDA is -$269.00M
What is 1-year change in RCUS annual EBITDA?
RCUS annual EBITDA is up +7.56% year-over-year
What is 3-year change in RCUS annual EBITDA?
RCUS annual EBITDA is down -555.93% over the past 3 years
How far is RCUS annual EBITDA from its all-time high?
RCUS annual EBITDA is currently -555.93% below its historical high of $59.00M set on December 31, 2021
How does RCUS annual EBITDA rank versus sector peers?
RCUS annual EBITDA is higher than 4.92% of companies in Healthcare sector
When is RCUS next annual earnings release?
The next annual earnings release for RCUS is on
Quarterly EBITDA
-$140.00M$134.00M-2,233.33%
Summary
- Current Value
- As of today, RCUS quarterly EBITDA is -$140.00M, down -2233.33% on
- Historical Performance
- RCUS quarterly EBITDA is down -35.92% year-over-year, and down -112.80% over the past 3 years
- All-Time High Comparison
- RCUS quarterly EBITDA is currently -149.34% below its historical high of $283.74M set on
- 3-Year Low Comparison
- RCUS quarterly EBITDA is at its 3-year low
- Sector Comparison
- RCUS quarterly EBITDA is higher than 1.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$140.00M | -2233.3% | -35.9% | -112.8% | -4224.9% | |
| Annual EBITDA | -$269.00M | – | +7.6% | -555.9% | -231.6% | |
| TTM EBITDA | -$365.00M | -11.3% | -27.6% | -511.3% | -327.3% | |
| Price | $21.35 | +41.9% | +43.1% | +15.5% | -30.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $26.00M | -83.8% | -45.8% | -22.6% | -59.7% | |
| Quarterly EPS | -$1.27 | -100.0% | -25.9% | -41.0% | -4627.1% | |
| Quarterly EBIT | -$142.00M | -1675.0% | -35.2% | -104.6% | -9249.5% | |
| Quarterly Net Income | -$135.00M | -100.0% | -46.7% | -108.0% | -7509.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$6.00M | -2233.3% | |
| 3Y | $7.00M | -2100.0% | |
| 5Y | $283.74M | -149.3% | |
| All | $283.74M | -149.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$140.00M | at low | |
| 3Y | -$140.00M | at low | |
| 5Y | -$140.00M | at low | |
| All | -$140.00M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RCUS?
As of today, RCUS quarterly EBITDA is -$140.00M
What is RCUS quarterly EBITDA most recent change?
RCUS quarterly EBITDA was down -2233.33% on September 30, 2025
What is 1-year change in RCUS quarterly EBITDA?
RCUS quarterly EBITDA is down -35.92% year-over-year
How far is RCUS quarterly EBITDA from its all-time high?
RCUS quarterly EBITDA is currently -149.34% below its historical high of $283.74M set on December 31, 2021
How does RCUS quarterly EBITDA rank versus sector peers?
RCUS quarterly EBITDA is higher than 1.63% of companies in Healthcare sector
When is RCUS next earnings release?
The next earnings release for RCUS is on
TTM EBITDA
-$365.00M$37.00M-11.28%
Summary
- Current Value
- As of today, RCUS TTM EBITDA is -$365.00M, down -11.28% on
- Historical Performance
- RCUS TTM EBITDA is down -27.62% year-over-year, and down -511.26% over the past 3 years
- All-Time High Comparison
- RCUS TTM EBITDA is currently -511.26% below its historical high of $88.75M set on
- 3-Year Low Comparison
- RCUS TTM EBITDA is +14.32% above its 3-year low of -$426.00M reached on
- Sector Comparison
- RCUS TTM EBITDA is higher than 2.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$365.00M | -11.3% | -27.6% | -511.3% | -327.3% | |
| Annual EBITDA | -$269.00M | – | +7.6% | -555.9% | -231.6% | |
| Quarterly EBITDA | -$140.00M | -2233.3% | -35.9% | -112.8% | -4224.9% | |
| Price | $21.35 | +41.9% | +43.1% | +15.5% | -30.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $240.00M | -8.4% | -8.8% | -44.5% | +208.6% | |
| TTM EPS | -$3.43 | -8.2% | -8.8% | -470.6% | -80.2% | |
| TTM EBIT | -$375.00M | -10.9% | -25.8% | -595.3% | -317.8% | |
| TTM Net Income | -$341.00M | -14.4% | -26.3% | -527.2% | -289.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$300.00M | N/A | -21.7% |
| 3Y | -$235.00M | -55.3% | |
| 5Y | $88.75M | -511.3% | |
| All | $88.75M | -511.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$426.00M | +14.3% | |
| 3Y | -$426.00M | +14.3% | |
| 5Y | -$426.00M | +14.3% | |
| All | -$426.00M | +14.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RCUS?
As of today, RCUS TTM EBITDA is -$365.00M
What is RCUS TTM EBITDA most recent change?
RCUS TTM EBITDA was down -11.28% on September 30, 2025
What is 1-year change in RCUS TTM EBITDA?
RCUS TTM EBITDA is down -27.62% year-over-year
How far is RCUS TTM EBITDA from its all-time high?
RCUS TTM EBITDA is currently -511.26% below its historical high of $88.75M set on September 30, 2022
How does RCUS TTM EBITDA rank versus sector peers?
RCUS TTM EBITDA is higher than 2.62% of companies in Healthcare sector
When is RCUS next earnings release?
The next earnings release for RCUS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- RCUS Official Website www.arcusbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1724521/000172452125000116/0001724521-25-000116-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1724521/000172452125000040/0001724521-25-000040-index.htm
- RCUS Profile on Yahoo Finance finance.yahoo.com/quote/RCUS
- RCUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rcus